Skip to main content
AYTU BIOPHARMA, INC logo

AYTU BIOPHARMA, INC — Investor Relations & Filings

Ticker · AYTU ISIN · US0547548745 US Manufacturing
Open in API
Filings indexed 890 across all filing types
Latest filing 2023-10-26 Regulatory Filings
Country US United States of America
Listing US AYTU

About AYTU BIOPHARMA, INC

https://aytubio.com/

Aytu BioPharma, Inc. is a specialty pharmaceutical company focused on developing and commercializing novel therapeutics. The company concentrates on advancing innovative medicines for complex central nervous system (CNS) diseases, with a particular emphasis on treatments for Attention-Deficit/Hyperactivity Disorder (ADHD) and Major Depressive Disorder (MDD). Its business model involves identifying, acquiring, and commercializing new products to improve the quality of life for patients with unmet medical needs.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text mentions a press release about the approval of a manufacturing site transfer supplement, which is attached as an exhibit. The document is short (3721 characters) and primarily serves as an announcement of this event rather than providing detailed financial data or comprehensive reports. It does not contain financial statements or detailed analysis, nor is it a certification or legal proceeding update. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2023-10-26 English
10-K
Annual Report FY 2023
2023-10-12 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated October 3, 2023, reporting the resignation of a Chief Operating Officer and related management changes. The key section is Item 5.02, which specifically addresses departure and appointment of officers. There is no financial data or report attached, nor is this an announcement of a report publication. The content clearly relates to changes in senior management. Therefore, the document fits the category of Board/Management Information (MANG). The document length is 3404 characters, which is short and consistent with a management change announcement rather than a full report.
2023-10-06 English
Director's Dealing 2023
Director's Dealing
2023-10-03 English
NT 10-K
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25, which is a Notification of Late Filing submitted to the SEC. It specifically states that the company, Aytu BioPharma, Inc., is unable to file its Annual Report on Form 10-K for the fiscal year ended June 30, 2023, by the prescribed due date and requests an extension of up to 15 days. The document does not contain the actual 10-K report or financial statements but is a notification about the delay in filing the 10-K. According to the rules, such a notification is a regulatory filing and not the report itself. Therefore, the correct classification is Regulatory Filings (RNS).
2023-09-29 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated September 27, 2023, by AYTU Biopharma, Inc. It announces the issuance of a press release containing financial results for the fiscal quarter and year ended June 30, 2023. The document itself does not contain the financial results but rather furnishes the press release as an exhibit. The text explicitly states that the press release is attached as Exhibit 99.1 and that the information is not deemed "filed" for certain regulatory purposes. The document length is 3611 characters, which is relatively short and consistent with an announcement rather than a full report. According to the "Menu vs Meal" rule, this is an announcement of a report (the press release) rather than the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other categories and includes Form 8-K filings announcing financial results via press releases.
2023-09-27 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.